Перейти к основному содержанию

User account menu

  • Войти

Языки

  • English
  • Français
  • Português
  • Español
  • العربية
  • Pусский

Основная навигация

  • Про ISSUP

    • Обоснование ISSUP
    • Членство
      • Критерии членства
      • Этический кодекс
      • Who is ISSUP for?
    • Новости
    • Международные партнеры
    • Управление
    • ISSUP Scientific Council
    • Friends of ISSUP (USA)
    • Семинары ISSUP
      • Bali 2025
      • Thessaloniki 2024
      • Buenos Aires 2023
      • Manila 2022
      • Abu Dhabi 2022
      • International Conference 2021 (Virtual)
      • Africa 2020 (Virtual)
      • Vienna 2019
      • Nairobi 2018
      • Cancún 2017
      • ISSUP Campinas 2016
      • ISSUP Tailandia 2015
    • Награды ISSUP
      • Награда за научно обоснованный подход
      • Награда за местную инициативу
      • Награда за заслуги
      • Высшее качество обучения
      • Награда за выдающийся вклад в развитие ISSUP
    • Страницы памяти
    • Acknowledgements
    • Путеводитель по сайту ISSUP
    • Свяжитесь с ISSUP
    • FAQs - Frequently Asked Questions
  • Профессиональное развитие

    • Центр онлайн-обучения
      • Как зарегистрироваться
      • Самостоятельные курсы UTC
    • Универсальные учебные программы (UPC/UTC)
      • Универсальная учебная программа по профилактике
      • Универсальная учебная программа по лечению
      • Универсальная учебная программа по восстановлению
      • Доступ к тренингам UPC и UTC
      • Поставщики обучения
      • Станьте поставщиком обучения
      • Глобальная программа обучения
    • Ресурсы
      • Glossary
      • Вебинары ISSUP
      • INEP Plus
      • Prevention Insights Video Series
      • Prevention Lists
      • Сертификация ICAP
      • HealthEKnowledge
      • WiRED International
      • Качество в лечении
      • Учебник по профилактике SPR-ISSUP
    • Доска вакансий
  • Knowledge Share

    • Search in the Knowledge Share
    • ADDICTOLOGY Journal
      • Последний номер
  • Национальные отделения

    • Africa
      • ISSUP Botswana
      • ISSUP Côte d’Ivoire
      • ISSUP Egypt
      • ISSUP The Gambia
      • ISSUP Kenya
      • ISSUP Namibia
      • ISSUP Nigeria
      • ISSUP South Africa
      • ISSUP Tanzania
      • ISSUP Togo
      • ISSUP Uganda
    • The Americas
      • ISSUP Argentina
      • ISSUP The Bahamas
      • ISSUP Brazil
      • ISSUP Canada
      • ISSUP Chile
      • ISSUP Colombia
      • ISSUP Ecuador
      • ISSUP El Salvador
      • ISSUP Guatemala
      • ISSUP Mexico
      • ISSUP Panama
      • ISSUP Paraguay
      • ISSUP Peru
      • ISSUP United States
    • Asia
      • ISSUP Afghanistan
      • ISSUP India
      • ISSUP Indonesia
      • ISSUP Kazakhstan
      • ISSUP Lebanon
      • ISSUP Malaysia
      • ISSUP in Pakistan
      • ISSUP Philippines
      • ISSUP Qatar
      • ISSUP Sri Lanka
      • ISSUP Thailand
      • ISSUP Türkiye
      • ISSUP United Arab Emirates
      • ISSUP Uzbekistan
      • ISSUP Vietnam
    • Europe
      • ISSUP Czech Republic
      • ISSUP Greece
      • ISSUP Italy
      • ISSUP Spain
      • ISSUP Ukraine
      • ISSUP United Kingdom
    • Как стать национальным отделением
    • Консультативный комитет национальных отделений ISSUP
  • Events

    • Search through all events
  • Сети

    • A–Z
  • Мой ISSUP

    • Member Directory
    • Подать заявку на членство

Medication Assisted Treatment (MAT)

Network to discuss various topics in MAT application and policy.
DiscussionsФайлыИзображенияVideosСсылкиМероприятияОбмен знаниямиВсе
Goodman Sibeko

2024 African Union Consultation for Drug Demand Reduction in Arusha, Tanzania

Shared by Goodman Sibeko - 13 December 2024
Attendees at the African Union Consultation for Drug Demand Reduction in Arusha, Tanzania

The African Union Commission (AUC) has held an annual continental consultation for Drug Demand Reduction (DDR) since 2015.  AUC member states are each represented by their respective DDR national focal points, allowing member states an opportunity to present national DDR activities in a peer-review platform that also allows engagement with invited subject matter experts.  This year’s consultation was held in Arusha, Tanzania from 10-13 December 2024, and included Traditional Leaders from Southern Africa. The theme for this year’s consultation was “Prevention is better than Cure: Towards...

Переводы
Español
العربية
Pashto
Indonesian
Italian
  • Подробнее о 2024 African Union Consultation for Drug Demand Reduction in Arusha, Tanzania
  • Добавить комментарий
Jose Luis Vazquez Martinez

Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville)

Jose Luis Vazquez Martinez - 22 March 2024
Source: Carrieri PM, Michel L, Lions C, Cohen J, Vray M, Mora M, et al. (2014) Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville). PLoS ONE 9(11): e112328. https://doi.org/10.1371/journal.pone.0112328 Abstract Objective Methadone coverage is...
Methadone Induction in Primary Care for Opioid Dependence A Pragmatic Randomized Trial ANRS Methaville.pdf
  • Подробнее о Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville)
  • Добавить комментарий
Jose Luis Vazquez Martinez

Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model

Jose Luis Vazquez Martinez - 1 December 2023
Source: Knudsen, H.K., Freeman, P.R., Oyler, D.R. et al. Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model. Addict Sci Clin Pract 18, 72 (2023). https://doi.org/10.1186/s13722-023-00426-6 Abstract Background...
Scaling up overdose education and naloxone distribution in Kentucky adoption and reach achieved through a hub with many spokes model.pdf
  • Подробнее о Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model
  • Добавить комментарий
James Harvey

Подать заявку на очное обучение на глобальном мероприятии в Салониках 2024

Shared by James Harvey (ISSUP staff) - 28 ноября 2023 r.
Глобальное событие 2024 года пройдет в Салониках, Греция, с 24 по 28 июня 2024 года. Мероприятие организовано ISSUP и ISSUP Greece, INL, Центрами по профилактике зависимостей, содействию психосоциальному здоровью SEIRIOS и ICUDDR.  Мероприятие пройдет в историческом центре города Салоники, на территории «Международного выставочного и конгресс-центра TIF-HELEXPO» и окружающих его конференц-залах в музеях и социальных учреждениях.
Мы рады сообщить, что регистрация на очные тренинги на глобальном мероприятии в Салониках 2024 уже открыта!
Переводы
English
Українська
Indonesian
Ελληνικά
Urdu
Vietnamese
  • Подробнее о Подать заявку на очное обучение на глобальном мероприятии в Салониках 2024
  • Добавить комментарий
Jose Luis Vazquez Martinez

Integrating Opioid Use Disorder Treatment Into Primary Care Settings

Jose Luis Vazquez Martinez - 11 August 2023
Source: Austin EJ, Chen J, Briggs ES, et al. Integrating Opioid Use Disorder Treatment Into Primary Care Settings. JAMA Netw Open. 2023;6(8):e2328627. doi:10.1001/jamanetworkopen.2023.28627 Key Points Question What are multidisciplinary primary care team perspectives on barriers and facilitators to...
Integrating Opioid Use Disorder Treatment Into Primary Care Settings.pdf
  • Подробнее о Integrating Opioid Use Disorder Treatment Into Primary Care Settings
  • Добавить комментарий
Jose Luis Vazquez Martinez

Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021

Jose Luis Vazquez Martinez - 10 August 2023
Source: Jones CM, Han B, Baldwin GT, Einstein EB, Compton WM. Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021. JAMA Netw Open. 2023;6(8):e2327488. doi:10.1001/jamanetworkopen.2023.27488 Discussion Despite guidelines recommending MOUD...
Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021.pdf
  • Подробнее о Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021
  • Добавить комментарий
Bartolome Perez-Galvez

Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS).

Bartolome Perez-Galvez - 27 May 2023
Source: Marel, C., Wilson, J., Darke, S., Ross, J., Slade, T., Haber, P. S., Haasnoot, K., Visontay, R., Keaveny, M., Tremonti, C., Mills, K. L., & Teesson, M. (2023). Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the...
Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence - Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS)_0.pdf
  • Подробнее о Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS).
  • Добавить комментарий
Jose Luis Vazquez Martinez

La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides

Jose Luis Vazquez Martinez - 24 Mayo 2023

Fuente: https://www.fda.gov/news-events/press-announcements/la-fda-aprueba-una-nueva-opcion-de-tratamiento-con-buprenorfina-para-el-trastorno-por-consumo-de

 

Para publicación inmediata: 24 de mayo del 2023

Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la inyección subcutánea (para uso por debajo de la piel) de Brixadi (buprenorfina) de liberación prolongada para tratar el trastorno por consumo de opioides (OUD, por sus siglas en inglés) de moderado a grave. Brixadi está disponible en dos formulaciones, una inyección semanal...

  • Подробнее о La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides
  • Добавить комментарий
Jose Luis Vazquez Martinez

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

Jose Luis Vazquez Martinez - 24 May 2023

Source: https://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder

 

For Immediate Release: May 23, 2023

Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two formulations, a weekly injection that can be used in patients who have started treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine, and...

  • Подробнее о FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
  • Добавить комментарий
Jose Luis Vazquez Martinez

Advisory: Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder

Jose Luis Vazquez Martinez - 23 May 2023
Source: https://store.samhsa.gov/sites/default/files/pep23-02-01-002.pdf This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of...
Advisory Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder_0.pdf
  • Подробнее о Advisory: Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder
  • Добавить комментарий
Jose Luis Vazquez Martinez

Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes

Jose Luis Vazquez Martinez - 22 May 2023
Source: Taylor EA, Cantor JH, Bradford AC, Simon K, Stein BD. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes. JAMA Netw Open. 2023;6(5):e2314328. doi:10.1001/jamanetworkopen.2023.14328 Key Points Question Did rates of methadone dispensing for opioid use...
Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes.pdf
  • Подробнее о Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes
  • Добавить комментарий
Jose Luis Vazquez Martinez

Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation

Jose Luis Vazquez Martinez - 22 May 2023
Source: Jakubowski, A., Singh-Tan, S., Torres-Lockhart, K. et al. Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract 18, 31 (2023). https://doi.org/10.1186/s13722-023-00386-x Abstract...
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder opportunities for training innovation_1.pdf
  • Подробнее о Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation
  • Добавить комментарий
Jose Luis Vazquez Martinez

Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review

Jose Luis Vazquez Martinez - 9 May 2023
Source: Onuoha, E. N., Leff, J. A., Schackman, B. R., McCollister, K. E., Polsky, D., & Murphy, S. M. (2021). Economic evaluations of pharmacologic treatment for opioid use disorder: a systematic literature review. Value in Health, 24(7), 1068-1083. Highlights There is new evidence on buprenorphine...
Click here → to read the full text
Переводы
العربية
  • Подробнее о Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
  • Добавить комментарий
Jose Luis Vazquez Martinez

Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl

Jose Luis Vazquez Martinez - 31 March 2023
Source: D’Onofrio G, Hawk KF, Perrone J, et al. Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. JAMA Netw Open. 2023;6(3):e236108. doi:10.1001/jamanetworkopen.2023.6108 Discussion This cohort study used data...
Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl.pdf
  • Подробнее о Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl
  • Добавить комментарий
Jose Luis Vazquez Martinez

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes

Jose Luis Vazquez Martinez - 23 August 2022
Source: Day, N., Wass, M. & Smith, K. Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes. Addict Sci Clin Pract 17, 40 (2022). https://doi.org/10.1186/s13722-022-00323-4 Abstract Background Virtually delivered healthcare (telehealth, telemedicine) has the...
Virtual opioid agonist treatment Alberta’s virtual opioid dependency program and outcomes.pdf
  • Подробнее о Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
  • Добавить комментарий
Jose Luis Vazquez Martinez

Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants

Jose Luis Vazquez Martinez - 11 August 2022
Source: Andraka-Christou, B., Page, C., Schoebel, V. et al. Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants. Addict Sci Clin Pract 17, 43 (2022). https://doi.org/10.1186/s13722-022-00321-6 Abstract Background Medications for opioid use disorder...
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants_0.pdf
  • Подробнее о Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants
  • Добавить комментарий
Jose Luis Vazquez Martinez

Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice

Jose Luis Vazquez Martinez - 27 July 2022
Source: Hodgins, D. C., Budd, M., Czukar, G., Dubreucq, S., Jackson, L. A., Rush, B., ... & Cameron Wild, T. (2022). Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice. The Canadian Journal of Psychiatry...
Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs A National Survey of Policy, Attitudes, and Practice_0.pdf
  • Подробнее о Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice
  • Добавить комментарий
Jose Luis Vazquez Martinez

Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities

Jose Luis Vazquez Martinez - 19 July 2022
Source: Pasman, E., Kollin, R., Broman, M. et al. Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities. Addict Sci Clin Pract 17, 35 (2022). https://doi.org/10.1186/s13722-022-00316-3 Abstract Background Though methadone has been shown to...
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities.pdf
  • Подробнее о Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities
  • Добавить комментарий
Jose Luis Vazquez Martinez

Methadone Treatment for Opioid Use Disorder Improving Access through Regulatory and Legal Change: Proceedings of a Workshop

Jose Luis Vazquez Martinez - 15 July 2022
Source: National Academies of Sciences, Engineering, and Medicine. 2022. Methadone Treatment for Opioid Use Disorder: Improving Access through Regulatory and Legal Change: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26635. Methadone is a Food and Drug...
Click here → to read the full text
  • Подробнее о Methadone Treatment for Opioid Use Disorder Improving Access through Regulatory and Legal Change: Proceedings of a Workshop
  • Добавить комментарий
Jose Luis Vazquez Martinez

The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance

Jose Luis Vazquez Martinez - 3 June 2022
Source: Meyers-Pantele, S.A., Mittal, M.L., Jain, S. et al. The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance. Subst Abuse Treat Prev Policy 17, 39 (2022). https://doi.org/10.1186/s13011-022-00470-6 Abstract...
The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance.pdf
  • Подробнее о The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance
  • Добавить комментарий

Нумерация страниц

  • Текущая страница 1
  • Страница 2
  • Страница 3
  • Страница 4
  • Страница 5
  • Следующая страница ››
  • Последняя страница Last »

Upcoming Events

There aren't any upcoming events
All Events
Связаться с нами

Stay Connected

Newsletter

ISSUP is funded by the U.S. Department of State via the Bureau of International Narcotics and Law Enforcement Affairs (INL). INL works to keep Americans safe by countering crime, illegal drugs, and instability abroad.

Copyright © International Society of Substance Use Prevention and Treatment Professionals Privacy Policy